ProShares UltraPro Nasdaq Biotechnology (UBIO) ETF Holdings & Analysis

What UBIO does

This fund aims to deliver daily returns equal to three times (3x) the daily movement of the NASDAQ Biotechnology Index, prior to accounting for fees and operating costs. To achieve this, it strategically deploys capital into various financial instruments, which ProShare Advisors expects will collectively mirror its ambitious daily performance target. The underlying index itself is a modified capitalization-weighted benchmark, comprising stocks of companies listed on Nasdaq that fall within the biotechnology or pharmaceutical sectors. It operates as a non-diversified fund.

Fund profile

Top holdings

Sector allocation

Geographic allocation

PortView Portfolio Insights

PortView analyzes how UBIO fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Related securities

Related stocks

Frequently asked questions

What does UBIO track?

UBIO is the ProShares UltraPro Nasdaq Biotechnology, a Other ETF.

What is the expense ratio of UBIO?

Expense ratio data for UBIO is shown on the page when available from our data provider.

What are the largest holdings in UBIO?

Top holdings include Net Other Assets (Liabilities).

How can PortView analyze UBIO overlap with other ETFs?

PortView computes the holdings overlap between UBIO and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.